BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31444696)

  • 1. Total testosterone density predicts high tumor load and disease reclassification of prostate cancer: results in 144 low-risk patients who underwent radical prostatectomy.
    Porcaro AB; Tafuri A; Sebben M; Processali T; Pirozzi M; Shakir A; Amigoni N; Rizzetto R; Brunelli M; Migliorini F; Siracusano S; Artibani W
    Int Urol Nephrol; 2019 Dec; 51(12):2169-2180. PubMed ID: 31444696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Influence of Endogenous Testosterone Density on Unfavorable Disease and Tumor Load at Final Pathology in Intermediate-Risk Prostate Cancer: Results in 338 Patients Treated with Radical Prostatectomy and Extended Pelvic Lymph Node Dissection.
    Porcaro AB; Panunzio A; Tafuri A; Cerrato C; Gallina S; Bianchi A; Rizzetto R; Amigoni N; Gozzo A; Serafin E; Cianflone F; Migliorini F; Vidiri S; Di Filippo G; Novella G; Brunelli M; Shakir A; Pagliarulo V; Cerruto MA; Siracusano S; Antonelli A
    Urol Int; 2022; 106(9):928-939. PubMed ID: 35081537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous testosterone density as ratio of endogenous testosterone levels on prostate volume predicts tumor upgrading in low-risk prostate cancer.
    Porcaro AB; Gallina S; Bianchi A; Cerrato C; Tafuri A; Rizzetto R; Amigoni N; Orlando R; Serafin E; Gozzo A; Migliorini F; Antoniolli SZ; Lacola V; De Marco V; Brunelli M; Cerruto MA; Siracusano S; Antonelli A
    Int Urol Nephrol; 2021 Dec; 53(12):2505-2515. PubMed ID: 34677784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Basal Total Testosterone Levels and Tumor Upgrading in Low and Intermediate Risk Prostate Cancer.
    Porcaro AB; De Luyk N; Corsi P; Sebben M; Tafuri A; Processali T; Cerasuolo M; Mattevi D; Cerruto MA; Brunelli M; Siracusano S; Artibani W
    Urol Int; 2017; 99(2):215-221. PubMed ID: 28245478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous testosterone density predicts unfavorable disease at final pathology in intermediate risk prostate cancer.
    Porcaro AB; Tafuri A; Panunzio A; Rizzetto R; Amigoni N; Cerrato C; Shakir A; Gallina S; Bianchi A; Cianflone F; Serafin E; Gozzo A; Di Filippo G; Migliorini F; Novella G; Brunelli M; Cerruto MA; Antonelli A
    Int Urol Nephrol; 2021 Dec; 53(12):2517-2526. PubMed ID: 34580803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy.
    Yashi M; Nukui A; Tokura Y; Takei K; Suzuki I; Sakamoto K; Yuki H; Kambara T; Betsunoh H; Abe H; Fukabori Y; Nakazato Y; Kaji Y; Kamai T
    BMC Urol; 2017 Jun; 17(1):47. PubMed ID: 28645325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance.
    Ferro M; Lucarelli G; Bruzzese D; Di Lorenzo G; PerdonĂ  S; Autorino R; Cantiello F; La Rocca R; Busetto GM; Cimmino A; Buonerba C; Battaglia M; Damiano R; De Cobelli O; Mirone V; Terracciano D
    Oncotarget; 2017 Mar; 8(11):18424-18434. PubMed ID: 27793023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous testosterone density is an independent predictor of pelvic lymph node invasion in high-risk prostate cancer: results in 201 consecutive patients treated with radical prostatectomy and extended pelvic lymph node dissection.
    Porcaro AB; Tafuri A; Panunzio A; Mazzucato G; Cerrato C; Gallina S; Bianchi A; Rizzetto R; Amigoni N; Serafin E; Cianflone F; Orlando R; Gentile I; Migliorini F; Zecchini Antoniolli S; Di Filippo G; Brunelli M; Pagliarulo V; Cerruto MA; Antonelli A
    Int Urol Nephrol; 2022 Mar; 54(3):541-550. PubMed ID: 35044553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy.
    Porcaro AB; Caruso B; Terrin A; De Luyk N; Cacciamani G; Corsi P; Inverardi D; De Marchi D; Baldassarre R; Cerruto M; Ghimenton C; Brunelli M; Zecchini Antoniolli S; Petrozziello A; Artibani W
    Arch Ital Urol Androl; 2016 Mar; 88(1):17-22. PubMed ID: 27072171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific antigen levels and proportion of biopsy positive cores are independent predictors of upgrading patterns in low-risk prostate cancer.
    Porcaro AB; Inverardi D; Corsi P; Sebben M; Cacciamani G; Tafuri A; Processali T; Pirozzi M; Mattevi D; De Marchi D; Amigoni N; Rizzetto R; Cerruto MA; Brunelli M; Siracusano S; Artibani W
    Minerva Urol Nefrol; 2020 Feb; 72(1):66-71. PubMed ID: 30298710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
    BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies.
    Ferro M; Lucarelli G; de Cobelli O; Vartolomei MD; Damiano R; Cantiello F; Crocerossa F; PerdonĂ  S; Del Prete P; Cordima G; Musi G; Del Giudice F; Busetto GM; Chung BI; Porreca A; Ditonno P; Battaglia M; Terracciano D
    World J Urol; 2021 Jun; 39(6):1861-1867. PubMed ID: 32683462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive Association between Preoperative Total Testosterone Levels and Risk of Positive Surgical Margins by Prostate Cancer: Results in 476 Consecutive Patients Treated Only by Radical Prostatectomy.
    Porcaro AB; Tafuri A; Sebben M; Corsi P; Pocessali T; Pirozzi M; Amigoni N; Rizzetto R; Mariotto A; Inverardi D; Brunelli M; Iacovelli R; Romano M; Siracusano S; Artibani W
    Urol Int; 2018; 101(1):38-46. PubMed ID: 29975957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low serum testosterone predicts upgrading and upstaging of prostate cancer after radical prostatectomy.
    Gao Y; Jiang CY; Mao SK; Cui D; Hao KY; Zhao W; Jiang Q; Ruan Y; Xia SJ; Han BM
    Asian J Androl; 2016; 18(4):639-43. PubMed ID: 26732103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies.
    Ferro M; Terracciano D; Musi G; de Cobelli O; Vartolomei MD; Damiano R; Cantiello F; Buonerba C; Morelli M; Mistretta FA; Luzzago S; PerdonĂ  S; Del Prete P; Del Giudice F; Busetto GM; Porreca A; Autorino R; Manfredi M; Porpiglia F; Muto M; Loizzo D; Ditonno P; Battaglia M; Lucarelli G
    Urol Int; 2022; 106(1):75-82. PubMed ID: 34167120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone Levels Correlate With Grade Group 5 Prostate Cancer: Another Step Toward Personalized Medicine.
    Capogrosso P; Ventimiglia E; Moschini M; Boeri L; Farina E; Finocchio N; Gandaglia G; Fossati N; Briganti A; Montorsi F; Salonia A
    Prostate; 2017 Feb; 77(2):234-241. PubMed ID: 27775173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Testosterone Preoperative Plasma Levels Independently Predict Biopsy Gleason Score Upgrading in Men with Prostate Cancer Undergoing Radical Prostatectomy.
    Porcaro AB; Petroziello A; Brunelli M; De Luyk N; Cacciamani G; Corsi P; Sebben M; Tafuri A; Tamanini I; Caruso B; Ghimenton C; Monaco C; Artibani W
    Urol Int; 2016; 96(4):470-8. PubMed ID: 26845458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum total testosterone is a significant preoperative variable independently contributing to separating the prostate cancer population into prostatectomy Gleason score groups.
    Porcaro AB; Petrozziello A; Ghimenton C; Migliorini F; Sava T; Caruso B; Cocco C; Romano M; Cavalleri S; Artibani W
    Urol Int; 2013; 91(1):55-61. PubMed ID: 23751412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
    Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
    BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive independent association between preoperative endogenous testosterone density and tumor load density in surgical specimen of patients undergoing radical prostatectomy.
    Porcaro AB; Bianchi A; Gallina S; Serafin E; Mazzucato G; Panunzio A; Tafuri A; Montanaro F; Marafioti Patuzzo G; Baielli A; Artoni F; Vidiri S; Cianflone F; D'Aietti D; Brunelli M; Siracusano S; Cerruto MA; Antonelli A
    Urologia; 2024 Feb; 91(1):76-84. PubMed ID: 37526101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.